New Oral Anticoagulant Drugs for the Treatment of Cerebral Venous Sinus Thrombosis

The therapy of cerebral venous sinus thrombosis is restricted to heparin and vitamin K antagonists. In last years, new oral anticoagulant treatments have been developed. Factor Xa inhibitors and thrombin inhibitors have been extensively used in prophylaxis of the ischemic stroke secondary to the atr...

Full description

Bibliographic Details
Main Author:	Birsen Ince
Format:	Article
Language:	English
Published:	Turkish Society of Cerebrovascular Diseases 2016-08-01
Series:	Türk Beyin Damar Hastalıkları Dergisi
Subjects:	Cerebral venous sinus thrombosis anticoagulant treatment new oral anticoagulants
Online Access:	http://www.journalagent.com/tbdhd/pdfs/TBDHD-83097-REVIEW-INCE.pdf

id	doaj-76fdf098e1c24930897a8ee9c337bb3c
record_format	Article
spelling	doaj-76fdf098e1c24930897a8ee9c337bb3c2020-11-25T00:53:14ZengTurkish Society of Cerebrovascular DiseasesTürk Beyin Damar Hastalıkları Dergisi2146-91132016-08-01222495110.5505/tbdhd.2016.83097New Oral Anticoagulant Drugs for the Treatment of Cerebral Venous Sinus ThrombosisBirsen InceThe therapy of cerebral venous sinus thrombosis is restricted to heparin and vitamin K antagonists. In last years, new oral anticoagulant treatments have been developed. Factor Xa inhibitors and thrombin inhibitors have been extensively used in prophylaxis of the ischemic stroke secondary to the atrial fibrillation. Direct oral anticoagulants have emerged as an option for anticoagulation in treatment of venous thromboembolism. In this review, the data related to the use of new oral anticoagulants in patients with cerebral venous sinus thrombosis has been revised.http://www.journalagent.com/tbdhd/pdfs/TBDHD-83097-REVIEW-INCE.pdfCerebral venous sinus thrombosisanticoagulant treatmentnew oral anticoagulants
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Birsen Ince
spellingShingle	Birsen Ince New Oral Anticoagulant Drugs for the Treatment of Cerebral Venous Sinus Thrombosis Türk Beyin Damar Hastalıkları Dergisi Cerebral venous sinus thrombosis anticoagulant treatment new oral anticoagulants
author_facet	Birsen Ince
author_sort	Birsen Ince
title	New Oral Anticoagulant Drugs for the Treatment of Cerebral Venous Sinus Thrombosis
title_short	New Oral Anticoagulant Drugs for the Treatment of Cerebral Venous Sinus Thrombosis
title_full	New Oral Anticoagulant Drugs for the Treatment of Cerebral Venous Sinus Thrombosis
title_fullStr	New Oral Anticoagulant Drugs for the Treatment of Cerebral Venous Sinus Thrombosis
title_full_unstemmed	New Oral Anticoagulant Drugs for the Treatment of Cerebral Venous Sinus Thrombosis
title_sort	new oral anticoagulant drugs for the treatment of cerebral venous sinus thrombosis
publisher	Turkish Society of Cerebrovascular Diseases
series	Türk Beyin Damar Hastalıkları Dergisi
issn	2146-9113
publishDate	2016-08-01
description	The therapy of cerebral venous sinus thrombosis is restricted to heparin and vitamin K antagonists. In last years, new oral anticoagulant treatments have been developed. Factor Xa inhibitors and thrombin inhibitors have been extensively used in prophylaxis of the ischemic stroke secondary to the atrial fibrillation. Direct oral anticoagulants have emerged as an option for anticoagulation in treatment of venous thromboembolism. In this review, the data related to the use of new oral anticoagulants in patients with cerebral venous sinus thrombosis has been revised.
topic	Cerebral venous sinus thrombosis anticoagulant treatment new oral anticoagulants
url	http://www.journalagent.com/tbdhd/pdfs/TBDHD-83097-REVIEW-INCE.pdf
work_keys_str_mv	AT birsenince neworalanticoagulantdrugsforthetreatmentofcerebralvenoussinusthrombosis
_version_	1725238571582881792

New Oral Anticoagulant Drugs for the Treatment of Cerebral Venous Sinus Thrombosis

Similar Items